International Journal of Nursing Care Innovations
Back to Articles Inpress
Research Article

Published on 9 Nov 2026

Effects of Maternal Analgesic and Epidural Anesthesia on Neonatal Apgar Score in Imo State University Teaching Hospital Orlu

Akidi Chinecherem Ritamary

  1. 1Department of Nursing Sciences, Faculty of Health Sciences, Imo State University, Owerri, Orlu Campus, Imo State

Full Text|Abstract|PDF|

Abstract

This study evaluated the influence of maternal analgesics and epidural anaesthesia on infant Apgar scores in deliveries at Imo State University Teaching Hospital (IMSUTH), Orlu. The study was guided by Neuman Systems Model. The study assessed the types of analgesics given during birth, Apgar scores of the neonates at 1 and 5 minutes, rate of newborn resuscitation and admission into the newborn Intensive Care Unit (NICU). Two null hypotheses were evaluated. The research design used was a retrospective cohort design, which consisted of 150 postpartum moms identified by sequential sampling. Data were gathered using a structured questionnaire and examined using descriptive statistics (frequencies and percentages) and Chi-square test of independence at the 0.05 level of statistical significance. The results revealed that 41.3% of the respondents received maternal analgesics. Non-opioid analgesics represented 67.7% of analgesic use and 9.3% received epidural anaesthesia. Majority of newborns delivered by moms who had taken analgesics or epidural anaesthesia had normal apgar scores (7 to 10) at 1 and 5 minutes after birth. Furthermore, hypothesis testing demonstrated no statistical significance between maternal analgesic use or epidural anaesthesia and infant Apgar scores (p > 0.05). The study did not find any significant association between maternal analgesics and epidural anaesthesia during delivery and unfavourable immediate neonatal Apgar scores in the study population. It is therefore recommended that health care providers continue to use appropriate and prudent labour pain management measures while providing adequate maternal, foetal and neonatal monitoring to promote safe obstetric outcomes.

Keywords: Maternal analgesics. Epidural anaesthesia. Neonatal outcome, Apgar score. Pain relief in childbirth.

Introduction

Pregnancy is a duration of around 40 weeks from the first day of the woman’s last menstrual cycle. Childbirth is a normal physiological process of delivery of a foetus from the uterus after completion of pregnancy. The labour process is defined by periodic uterine contractions, gradual cervical dilatation and effacement, descent of the foetus and final birth of the infant, followed by evacuation of the placenta. Traditionally, labour is split into three stages. The first stage is cervical effacement and dilatation, the second stage is from full cervical dilatation to the delivery of the baby and the third stage is the separation and evacuation of placenta. Physiologically, childbirth is a normal event, although it is often linked with significant pain and discomfort. The severity of pain and discomfort varies among women, depending on specific physiological, psychological and obstetric factors[1]

Labour pain is one of the most severe acute pain women encounter and may cause substantial physiological and psychological responses. Severe pain and anxiety in labour activate the sympathetic nervous system resulting in increased circulating catecholamines, maternal tachycardia, increased oxygen consumption and changes in uteroplacental blood flow. Such physiologic reactions may possibly impair foetal oxygen transport, especially in conjunction with maternal hyperventilation and acid-base disorders. Adequate pain management in childbirth is critical not just for maternal comfort but also for maternal and foetal welfare [2]. Therefore, proper pain management is a vital part of modern obstetric treatment, with the aim to reduce maternal suffering and promote good maternal and newborn outcomes[3].

Maternal analgesia is the employment of pharmacologic medicines to relieve pain during labour and delivery. Opioid and non-opioid medicines are among the several kinds of analgesics that are employed in obstetric treatment. Commonly used opioid analgesics include morphine, fentanyl, pethidine and related compounds. Non-opioid alternatives may include paracetamol and some non-steroidal anti-inflammatory medicines depending upon the clinical indication and stage of pregnancy. These drugs differ in their mode of action, potency, duration of impact and potential side effects. Although analgesics give great relief from labour pain, some drugs, particularly systemic opioids, can pass the placental barrier and affect the physiological functioning of the foetus or neonate. Neonatal effects may include respiratory depression, decreased muscular tone, altered reflex responses and abnormalities in early neonatal adaption depending on the substance used, dosage, time and interval between administration and delivery[4].

Epidural analgesia is another well-known way of pain reduction during delivery. It is a type of neuraxial analgesia where local anaesthetic drugs occasionally mixed with opioids are injected in the epidural area using a catheter to block transmission of pain impulses through spinal nerve roots. Epidural anaesthesia includes the introduction of anaesthetic medicine into the epidural space to cause sensory blockage [5]. The extent of motor blockade is dependent on the substances, concentrations and doses delivered. The most commonly used drugs for epidural analgesia are bupivacaine, ropivacaine and local anaesthetics coupled with opioids (e.g. fentanyl or sufentanil). Epidural analgesia is an efficient method of pain control that reduces the transmission of pain signals from the uterus, cervix and birth canal and enables women to be conscious and to actively engage in the birthing process [6]

Epidural analgesia is effective but may result in certain physiological repercussions to the mother and foetus. Hypotension in the mother following sympathetic blockade is a known consequence that if not treated promptly may impair uteroplacental perfusion. Therefore foetal health during labour can be influenced by alterations in maternal blood pressure, uterine activity and foetal heart rate. Moreover, interest has been aroused in investigating the association between epidural analgesia and immediate newborn outcomes, considering the systemic absorption of medicines and possible impacts on neonatal adaption. However the extent of these effects depend on various aspects such as kind and concentration of medicine, dosage, time of administration, maternal state and clinical circumstances surrounding delivery[7].

The Apgar score is one of the most used methods to determine the immediate physiological state of a new born. Apgar score, a measure developed in 1952 by Virginia Apgar to quickly summarise the health of newborn children immediately after birth It is measured at one and five minutes after birth and has five components: appearance (skin colour), pulse (heart rate), grimace (reflex irritability), activity (muscle tone) and respiration (breathing effort). Each component is scored 0, 1 or 2. The maximum total score is 10. Generally, a score of 7–10 is encouraging, scores of 4–6 suggest substantially abnormal newborn adaptation, and scores of 0–3 suggest significantly abnormal adaptation. The 1-minute Apgar score indicates the newborn’s first adjustment to extra-uterine life, while the 5-minute score adds information regarding the infant’s response to any resuscitation and further adjustment. The Apgar score is an important clinical assessment tool but should not be used in isolation to confirm the existence of birth asphyxia or to predict long term neurological outcomes[8].

There have been several research examining the probable association between mother anaesthetic procedures and neonatal Apgar ratings. A comparative evaluation of neonatal results after general and spinal anaesthesia for elective caesarean deliveries has not found a statistically significant difference in mean Apgar scores between the groups. This data implies that adequately administered anaesthetic procedures may not invariably hinder initial newborn adaption. However, several studies have revealed differences in newborn outcomes related to the time and administration of epidural analgesia in labour[9]. There are reports that epidural analgesia for an advanced cervical dilatation of 9 cm or more was connected with specific poor perinatal outcomes such as foetal bradycardia, the need for neonatal oxygen therapy and neonatal intensive care unit admission. The study also found greater prevalence of low one minute Apgar scores in women who had received epidural analgesia at cervical dilation of 4 cm or less[10]. The results imply that the connection between maternal analgesia, epidural administration and neonatal outcomes may be affected by the time of the intervention and other obstetric variables.

There is evidence to support the benefits of maternal analgesics and epidural analgesia in easing the delivery experience, but there are worries about their possible effect on immediate infant outcomes. Some of the pharmacological medications delivered during labour may penetrate the placenta and transiently influence neonatal respiratory effort, heart rate, muscle tone and reflex irritability, which are significant components of the Apgar grading system. Such consequences may increase the likelihood that the newborn will need resuscitation, supplemental oxygen, or admission to the neonatal intensive care unit (NICU). However, studies have shown inconsistent findings, with some researchers suggesting worse newborn outcomes and others have found no significant changes in Apgar scores between exposed and unexposed neonates. These variances suggest that further research is needed in diverse obstetric contexts and populations.

Management of labour pain is a major component of obstetric care in tertiary health institutes like Imo State University Teaching Hospital (IMSUTH), Orlu. Maternal analgesics and epidural analgesia may be used to increase maternal comfort and aid in birth management. However, the neonatal outcomes following exposure to these interventions might be determined by maternal features, the type and dose of medication given, the time of administration, the duration of labour, the manner of delivery and other obstetric or neonatal factors. Besides, there is limited institution-based research on the association between maternal analgesic use, epidural analgesia and neonatal Apgar scores among births conducted at IMSUTH, Orlu. This link is significant in assessing current obstetric pain management strategies and enhancing evidence-based maternal and newborn care.

This study therefore evaluated the effects of maternal analgesics and epidural anaesthesia on neonatal Apgar score in births at Imo State University Teaching Hospital, Orlu. It specifically looked at the types of maternal analgesics used, the use of epidural anaesthesia, newborn Apgar scores at one and five minutes after birth, and the rates of neonatal resuscitation and NICU admission. The study also looked at the association between maternal analgesic usage, epidural anaesthesia and infant Apgar ratings. The results of this study are expected to furnish institution-specific evidence which may assist obstetric healthcare professionals in making informed decisions on labour pain management, facilitate appropriate monitoring of foetal and neonatal wellbeing and contribute to improved maternal and neonatal outcomes.

Materials and Methods

Study Design

A retrospective cohort study was conducted to evaluate the effects of maternal analgesics and epidural anaesthesia on neonatal Apgar scores among deliveries at Imo State University Teaching Hospital (IMSUTH), Orlu, Imo State, Nigeria. The study examined maternal exposure to analgesics and epidural anaesthesia during labour and their relationship with neonatal outcomes, including Apgar scores at one and five minutes after birth, the need for neonatal resuscitation and admission into the Neonatal Intensive Care Unit (NICU). The retrospective approach enabled the assessment of previously documented maternal exposures and corresponding neonatal outcomes.

Study Setting

The study was conducted at Imo State University Teaching Hospital (IMSUTH), Orlu, Imo State, Nigeria. The hospital is a tertiary healthcare institution providing specialised medical, surgical, obstetric, maternal and neonatal services to Orlu and surrounding communities. Its obstetric and neonatal units provide antenatal, intrapartum and postnatal care, including the management of normal and complicated deliveries. The availability of maternal and neonatal clinical records made the institution suitable for investigating the relationship between labour pain-management interventions and immediate neonatal outcomes.

Ethical Considerations

Ethical approval was obtained from the appropriate Research Ethics Committee of Imo State University Teaching Hospital, Orlu, before commencement of the study. Institutional permission was also obtained from the hospital management. Informed consent was obtained from participants involved in the supplementary questionnaire component. Confidentiality and anonymity were maintained throughout the research process by excluding personal identifiers from the analytical dataset. Participation was voluntary, and respondents were informed of their right to withdraw without affecting their access to healthcare services. Data obtained were used exclusively for research purposes.

Study Population and Sample Size

The study population comprised women who underwent labour and delivery at IMSUTH between 1 February and 30 September 2026. The accessible population consisted of 240 eligible women whose delivery records were available within the study period.

The sample size was determined using the Taro Yamane formula for a known population:

n = N / [1 + N(e)2]

Where (n) represents the required sample size, (N) is the accessible population (240), and (e) is the margin of error (0.05).

Substitution yielded:

n = 240 / [1 + 240(0.05)2]  =  240 / 1.6  =  150

Consequently, 150 eligible women were included in the study.

Sampling Technique

A consecutive sampling technique was employed to select eligible participants from the accessible population. Women who met the inclusion criteria were identified consecutively from the hospital records and approached for participation where supplementary questionnaire information was required. Recruitment continued until the calculated sample size of 150 was achieved. The selection included women who received analgesics, epidural anaesthesia, both interventions or neither intervention during labour.

Eligibility Criteria

Women who delivered at IMSUTH between February and September 2026 and had documented information on maternal analgesic use, epidural anaesthesia and neonatal Apgar scores were eligible for inclusion. Both exposed and unexposed women were considered to facilitate comparison of neonatal outcomes.

Records with incomplete information on maternal exposure or neonatal Apgar scores were excluded. Women who declined participation in the supplementary questionnaire component were also excluded where their participation was necessary to obtain the required information.

Data Collection Instrument and Procedure

Data were collected using a researcher-designed structured questionnaire and a clinical data extraction form developed in accordance with the study objectives. The instruments captured relevant maternal, obstetric, pharmacological and neonatal information.

The questionnaire consisted of four sections. Section A covered maternal sociodemographic and obstetric characteristics, including age, parity and gestational age at delivery. Section B documented maternal analgesic use, including the type of medication, route of administration and timing of administration. Section C captured information on epidural anaesthesia, including its administration and timing during labour. Section D documented neonatal outcomes, particularly Apgar scores at one and five minutes, the need for neonatal resuscitation and NICU admission.

Relevant information was extracted from maternal and neonatal clinical records to verify reported medication exposure and neonatal outcomes. The women were categorised according to their exposure status as those who received analgesics only, epidural anaesthesia only, both interventions, or neither intervention.

Validity and Reliability of the Instrument

The data collection instruments were reviewed by the research supervisor and experts in maternal and child health, obstetric nursing and research methodology to establish face and content validity. Their recommendations regarding the relevance, clarity and adequacy of the items were incorporated before the commencement of data collection.

A pilot assessment was conducted using a small group of eligible postpartum women outside the main study sample to evaluate the clarity and practicality of the questionnaire. Necessary modifications were made following the pilot assessment. Clinical information was cross-checked against the relevant hospital records to improve data accuracy and consistency.

Study Variables and Outcome Measures

The primary exposure variables were maternal analgesic administration and epidural anaesthesia during labour. Maternal analgesic exposure was further classified according to the type of medication administered, while epidural exposure was determined from documented anaesthetic records.

The primary outcome variables were neonatal Apgar scores at one and five minutes after birth. Apgar scores were categorised as reassuring (7–10) and low (below 7) for comparative analysis. Secondary neonatal outcomes included the need for resuscitation and admission into the NICU.

Statistical Analysis

Data were coded and analysed using the Statistical Package for Social Sciences (SPSS). Descriptive statistics, including frequencies and percentages, were used to summarise categorical variables, while means and standard deviations were calculated for continuous variables where appropriate.

Associations between maternal analgesic use, epidural anaesthesia and neonatal Apgar scores were evaluated using the Chi-square test of independence. Fisher’s exact test was considered where expected cell frequencies were insufficient for valid Chi-square approximation. Statistical significance was established at a two-sided p-value of less than 0.05.

Results

Table 1: Sociodemographic and Obstetric Characteristics of Respondents (N = 150)

Variable

Category

Frequency

Percentage (%)

Maternal age (years)

18–25

15

10.0

26–33

112

74.7

34–41

18

12.0

42 and above

5

3.3

Total

150

100.0

Parity

Primipara

30

20.0

Multipara

98

65.3

Grand multipara

22

14.7

Total

150

100.0

Gestational age at delivery

Preterm (<37 weeks)

12

8.0

Term (37–42 weeks)

132

88.0

Post-term (>42 weeks)

6

4.0

Total

150

100.0

Mode of delivery

Spontaneous vaginal delivery

92

61.3

Instrumental delivery (forceps/vacuum)

20

13.3

Caesarean section

38

25.3

Total

150

100.0

Table 2: Distribution of Respondents According to Maternal Analgesic Use and Epidural Anaesthesia (N = 150)

Variable

Category

Frequency

Percentage (%)

Receipt of maternal analgesics

Yes

62

41.3

No

88

58.7

Total

150

100.0

Category of analgesics received (n = 62)

Opioid analgesics

20

32.3

Non-opioid analgesics

42

67.7

Inhalational analgesics

0

0.0

Total

62

100.0

Route of administration (n = 62)

Intramuscular

22

35.5

Intravenous

18

29.0

Oral

22

35.5

Inhalation

0

0.0

Total

62

100.0

Stage of labour at administration (n = 62)

First stage

45

72.6

Second stage

17

27.4

Total

62

100.0

Receipt of epidural anaesthesia

Yes

14

9.3

No

136

90.7

Total

150

100.0

Table 3: Neonatal Apgar Scores Among Mothers Who Received Maternal Analgesics (n = 62)

Neonatal outcome

Apgar score category

Frequency

Percentage (%)

1-minute Apgar score

7–10

51

82.3

Below 7

11

17.7

Total

62

100.0

5-minute Apgar score

7–10

56

90.3

Below 7

6

9.7

Total

62

100.0

Table 4: Neonatal Apgar Scores Among Mothers Who Received Epidural Anaesthesia (n = 14)

Neonatal outcome

Apgar score category

Frequency

Percentage (%)

1-minute Apgar score

7–10

11

78.6

Below 7

3

21.4

Total

14

100.0

5-minute Apgar score

7–10

11

78.6

Below 7

3

21.4

Total

14

100.0

Table 5: Neonatal Resuscitation and NICU Admission/Oxygen Therapy Among Exposed Groups

Exposure group

Neonatal clinical outcome

Frequency

Percentage (%)

Maternal analgesics (n = 62)

NICU admission/oxygen therapy

6

9.7

Resuscitation immediately after birth

3

4.8

Epidural anaesthesia (n = 14)

NICU admission/oxygen therapy

3

21.4

Resuscitation immediately after birth

3

21.4

Table 6: Chi-square Analysis of the Association Between Maternal Analgesic Use and Neonatal Apgar Scores

Variable

χ² value

df

p-value

Significance level

Decision

Maternal analgesic use and neonatal Apgar scores

1.842

1

0.175

0.05

Not significant

Table 7: Chi-square Analysis of the Association Between Epidural Anaesthesia and Neonatal Apgar Scores

Variable

χ² value

df

p-value

Significance level

Decision

Epidural anaesthesia and neonatal Apgar scores

1.124

1

0.289

0.05

Not significant

Discussion

Results of this study suggest that some women were given pharmacological pain relief during birth, while a significant minority received no pharmacological analgesia. The most widely used analgesics were non-opioid drugs, whereas opioid medications were used less frequently. No inhalational analgesia was administered. The intramuscular and oral methods were used often, followed by intravenous delivery. Analgesics were more often given in the initial stage of labour than in the second stage[11].

The preponderance of non-opioid analgesics shows that these drugs were the main pharmacological strategy for the management of labour pain in the study environment. This pattern may be impacted by drug availability, institutional practices, cost considerations and the clinical preferences of the attending healthcare providers. The very limited use of epidural anaesthesia also implies that access to specialised neuraxial pain-management treatments may be limited within the hospital environment.

This is in line with the more general discussions by [12,13] who highlighted differences in the availability and use of labour analgesia between different healthcare settings. Similarly, institutional and resource related difficulties affecting provision of epidural labour analgesia in Nigerian healthcare settings have been discussed[13]. The pattern found in the present study may therefore be a reflection of the influence of institutional resources, availability of skilled anaesthetic experts and organization of obstetric services.

Pain during the first stage of labour could be connected with more frequent administration of analgesics in this stage due to painful uterine contractions and dilation of cervix. However, timing and choice of analgesia should be determined by maternal choice, clinical assessment, obstetric indications and stage of labour.

The results show that the majority of infants whose mothers received maternal analgesics had favourable Apgar scores at the first and fifth minutes after birth. The improvement in Apgar ratings between the two evaluation periods implies that many of the babies showed good early adaption after delivery. This is a crucial observation as the Apgar score is a quick clinical assessment of the newborn’s status and responsiveness to the instant transition from intrauterine to extrauterine life.

In most of the infants whose moms had epidural anaesthesia, Apgar scores were reassuring at the assessment intervals. However, the recurrence of low Apgar scores in certain newborn infants suggests that neonatal compromise can still occur and should not be ignored. Epidural analgesia can be associated with maternal haemodynamic alterations, notably hypotension. These may influence uteroplacental perfusion if not promptly detected and controlled. This underlines the significance of proper maternal monitoring during and after epidural administration[14].

For other neonatal outcomes, several babies in both exposure groups needed resuscitation, oxygen therapy or admission to neonatal intensive care unit. These results indicate that newborn assistance may be required even after maternal pain-relief measures have been given. The slightly higher rate of reported newborn interventions in the epidural group should be taken with caution, because to the small number of women who got this intervention. Other maternal, foetal and obstetric variables may have had a role in these results.

The present findings might be viewed in light of observations by [15] who investigated newborn outcomes related to labour analgesia and observed generally good outcomes after appropriate analgesic measures. Similarly it has been mentioned the influence of anaesthetic procedures and analgesic regimens on immediate neonatal adaption, highlighting the significance of drug selection, dose, time of administration and proper obstetric monitoring[16].

The data clearly indicate that reassuring neonatal Apgar ratings were common following maternal exposure to painkillers and epidural anaesthesia. However, the incidence of low Apgar scores and requirement for further neonatal assistance highlights the necessity for ongoing foetal monitoring, proper planning for neonatal resuscitation and quick assessment of babies after birth.

The first hypothesis was on the relationship between maternal analgesic usage and infant Apgar scores. The statistical study did not show a statistically significant association between the administration of maternal analgesics and the neonatal Apgar scores. The null hypothesis was therefore not disproved.

This result indicates that maternal analgesic use was not substantially related to the categorised neonatal Apgar outcomes in the study population. But this should not be taken as evidence that all analgesic drugs have similar effects on the newborn or that maternal analgesia is devoid of neonatal hazards. Analgesic drugs vary in their pharmacologic qualities, placental transfer characteristics, and possible consequences on infant respiratory function. Clinical effects may also depend on the dose, method and timing of administration in respect to delivery.

This finding is in line with the overall observations of [17] who addressed the link between analgesia, anaesthetic exposure and neonatal adaptability. However, comparisons of findings among research must account differences in study design, drug regimes, maternal factors and techniques of newborn assessment.

The absence of a statistically significant connection in the present investigation may possibly be influenced by the study design, the characteristics of the sample and other obstetric factors that were not thoroughly controlled. Therefore, the results indicate that the results should be interpreted with caution and that a final conclusion that maternal analgesics do not affect newborn outcomes is not justified.

The second hypothesis assessed the relationship between epidural anaesthesia and neonatal Apgar scores. Statistical research failed to demonstrate a statistically significant association between epidural anaesthesia and the Apgar scores of the neonate. Hence, the second null hypothesis was not refuted.

This observation indicates that the epidural anaesthesia was not substantially connected with the categorised Apgar results among the infants studied. However, this finding should be interpreted with caution in view of the very small number of women receiving epidural anaesthetic. A small exposure group may limit the statistical power of a study to detect meaningful changes, especially if neonatal outcomes are relatively rare.

The finding can be compared to [18], who observed no significant changes in neonatal Apgar scores comparing anaesthetic procedures in elective caesarean sections. Although the context of their study is different from the present study their findings are a basis for analysing the association between anaesthetic procedures and immediate infant outcomes. However differences in anaesthesia type, therapeutic indications and patient characteristics must be acknowledged.

Epidural analgesia continues to be a valuable alternative in the management of pain in childbirth but requires appropriate clinical assessment and monitoring for its delivery. Maternal blood pressure, foetal heart rate and quick detection of problems should be given special attention. Thus the results of the present study reinforce the necessity for evidence-based epidural management, and not the assumption that absence of a statistically significant connection excludes all putative newborn risks[19].

The findings of this study can be viewed within the framework of the Neuman Systems Model which conceptualises persons as open systems that are in constant interaction with environmental stressors and use protective mechanisms to preserve stability. Labour pain, in the setting of childbirth, is a physiological and psychological stressor that may impact maternal comfort, mental health, and physiological responses.

Maternal analgesics and epidural anaesthesia may be perceived as interventions that help to alleviate stress related to childbirth pain. Nurses and midwives can enhance maternal comfort with appropriate pain management, while monitoring mother and foetal wellbeing closely. The model additionally highlights the need to recognise potential stressors and implement preventive steps to safeguard the stability of the mother and newborn.

The predominance of reassuring infant Apgar scores and the absence of statistically significant relationships in the hypothesis tests are consistent with the model’s emphasis on preserving physiological stability through suitable interventions. But the presence of poor Apgar scores and the requirement for neonatal assistance indicate that birthing is still a clinical procedure that requires constant evaluation and prompt intervention. The concept stresses the need for tailored care, maternal monitoring, foetal surveillance, and coordinated neonatal support[20].

The findings have substantial implications for nursing and midwifery practice, maternal health education, nursing administration and research. Nurses and midwives play a key part in measuring birth pain and assisting maternal comfort, as well as monitoring maternal and newborn care. They should give relevant information on pain treatment choices available and encourage customised decisions based on maternal preferences and clinical indications. A fundamental feature of intrapartum care should continue to be the ongoing surveillance of mother vital signs, uterine activity and foetal heart rate. The findings underline the significance of antenatal education on pain relief in delivery. Pregnant women should be informed about the choices for pain treatment accessible to them, both pharmaceutical and non-pharmacological, their prospective advantages, possible harmful effects and the necessity of informed decision-making. This instruction can decrease fear and misconceptions about analgesia and epidural treatment in labour. The low use of epidural anaesthesia suggests that hospital administrators should consider the availability and accessibility of professional obstetric pain-management services. Staffing, specific training, availability of equipment and the administration of evidence-based labour analgesia require collaboration between nursing management, obstetric departments and anaesthetic services. The results underline the necessity of strengthening nursing education in the areas of pharmaceutical pain management, newborn assessment, and interpretation of Apgar ratings. Further studies should examine the association between specific analgesic medications, dose, timing of administration, and newborn outcomes while controlling for important maternal and obstetric variables [21].

Conclusion

The results of this study revealed that conventional maternal analgesics used were more prevalent than epidural anaesthesia during delivery at Imo State University Teaching Hospital, Orlu. Most neonates born to moms who underwent these therapies had reassuring Apgar scores after birth, while some required further neonatal support. Statistical analyses did not reveal significant relationships of maternal analgesic usage, epidural anaesthesia and infant Apgar scores.

However, results should be interpreted with caution, especially when considering the small epidural exposure group and the potential for other maternal and obstetric factors to influence neonatal outcome. Hence, appropriate labour pain management should be advocated together with tailored clinical assessment, maternal and foetal monitoring and quick neonatal evaluation after delivery.

References

  1. Otokwala, J.G., Fyneface-Ogan, S. and Mato, C.N. (2013). Comparative effects of single-shot low-dose spinal bupivacaine only and bupivacaine with fentanyl on labour outcome. Nigerian Journal of Medicine, 22(4), 279–285

  2. Wang, K., Cao, L., Deng, Q., Sun, L.Q., Gu, T.Y., Song, J. and Qi, D.Y. (2014). The effects of epidural/spinal opioids in labour analgesia on neonatal outcomes: a meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia, 61(8), 695–709.

  3. Finster, M. and Wood, M. (2005). The Apgar score has survived the test of time. Anesthesiology, 102(4), 855–857.

  4. Ramin, S.M., Gambling, D.R., Lucas, M.J., Sharma, S.K., Sidawi, J.E. and Leveno, K.J. (1995). Randomized trial of epidural versus intravenous analgesia during labor. Obstetrics and Gynecology, 86(5), 783–789.

  5. Leighton, B.L. and Halpern, S.H. (2002). The effects of epidural analgesia on labor, maternal, and neonatal outcomes: a systematic review. American Journal of Obstetrics and Gynecology, 186(5 Suppl), S69–S77.

  6. Anim-Somuah, M., Smyth, R.M.D., Cyna, A.M. and Cuthbert, A. (2018). Epidural versus non-epidural or no analgesia for pain management in labour. Cochrane Database of Systematic Reviews, 5, CD000331.

  7. Smith, L.A., Burns, E. and Cuthbert, A. (2018). Parenteral opioids for maternal pain management in labour. Cochrane Database of Systematic Reviews, 6, CD007396.

  8. Høtoft, D. and Maimburg, R.D. (2021). Epidural analgesia during birth and adverse neonatal outcomes: a population-based cohort study. Women and Birth, 34(3), e286–e291.

  9. Wong, C.A., McCarthy, R.J., Sullivan, J.T., Scavone, B.M., Gerber, S.E. and Yaghmour, E.A. (2009). Early compared with late neuraxial analgesia in nulliparous labor induction: a randomized controlled trial. Obstetrics and Gynecology, 113(5), 1066–1074.

  10. Yau, G., Gregory, M.A., Gin, T., Bogod, D.G. and Oh, T.E. (1990). The addition of fentanyl to epidural bupivacaine in first-stage labour. Anaesthesia and Intensive Care, 18(4), 532–535.

  11. Lindow, S.W., Dhillon, A.R., Husaini, S.W. and Russell, I.F. (2004). A randomised double-blind comparison of epidural fentanyl versus fentanyl and bupivacaine for pain relief in the second stage of labour. BJOG: An International Journal of Obstetrics and Gynaecology, 111(10), 1075–1080.

  12. World Health Organization (2018). WHO recommendations: intrapartum care for a positive childbirth experience. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789241550215

  13. Sharma, S.K., Sidawi, J.E., Ramin, S.M., Lucas, M.J., Leveno, K.J. and Cunningham, F.G. (1997). Cesarean delivery: a randomized trial of epidural versus patient-controlled meperidine analgesia during labor. Anesthesiology, 87(3), 487–494.

  14. Wong, C.A., Scavone, B.M., Peaceman, A.M., McCarthy, R.J., Sullivan, J.T., Diaz, N.T. and Yaghmour, E. (2005). The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. New England Journal of Medicine, 352(7), 655–665.

  15. Hussein, M., Yousef, G. G. E., Mohamed Fawzy, K. A. M., & Fawzy, I. F. I. (2026). Does paracetamol offer effective pain relief compared with meperidine in primiparous women in labor? A randomized controlled trial. Egyptian Bulletin of Women’s Health Journal, 16(1), 1–7

  16. Ohel, G., Gonen, R., Vaida, S., Barak, S. and Gaitini, L. (2006). Early versus late initiation of epidural analgesia in labor: does it increase the risk of cesarean section? A randomized trial. American Journal of Obstetrics and Gynecology, 194(3), 600–605.

  17. Lieberman, E., Lang, J.M., Frigoletto, F.D., Richardson, D.K., Ringer, S.A. and Cohen, A. (1997). Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics, 99(3), 415–419.

  18. Kearns, R.J., Kyzayeva, A., Singh, S., Lawlor, D.A., Shaw, M. and Nelson, S. (2026). Epidural analgesia in labour and neonatal and childhood outcomes: national population based cohort study. BMJ, 394, e343320.

  19. Viscomi, C.M. and Manullang, T. (2000). Maternal fever, neonatal sepsis evaluation, and epidural labor analgesia. Regional Anesthesia and Pain Medicine, 25(5), 549–553.

  20. Goetzl, L., Cohen, A., Frigoletto, F.D., Ringer, S.A., Lang, J.M. and Lieberman, E. (2001). Maternal epidural use and neonatal sepsis evaluation in afebrile mothers. Pediatrics, 108(5), 1099–1102.

Kearns, R.J., Shaw, M., Gromski, P.S., Iliodromiti, S., Lawlor, D.A. and Nelson, S.M. (2021). Association of epidural analgesia in women in labor with neonatal and childhood outcomes in a population cohort. JAMA Network Open, 4(10), e21

Citation: Akidi CR and Ibebuike JE (2026). Effects of Maternal Analgesic and Epidural Anesthesia on Neonatal Apgar Score in Imo State University Teaching Hospital Orlu. Int. J. Nurs. Care Innov.